Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bubeník

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Folia Biologica|March 24, 2000
Dendritic-cell-based cancer vaccinesJ Bubeník
International Journal of Oncology|February 17, 2001
Genetically engineered dendritic cell-based cancer vaccines (review)J Bubeník
Journal of Cancer Research and Clinical Oncology|August 15, 2001
Utilization of oncoprotein-pulsed dendritic cells as tumor vaccinesJ Bubeník
Journal of Cancer Research and Clinical Oncology|January 1, 1990
Local and regional immunotherapy of cancer with interleukin 2J Bubeník
Folia Biologica|January 1, 1993
IL-2 gene therapy of cancer: at its beginningJ Bubeník
Folia Biologica|February 19, 2010
Genetically modified vaccines augment the efficacy of cancer surgery and chemotherapyJ Bubeník
Folia Biologica|December 23, 2006
Depletion of Treg cells augments the therapeutic effect of cancer vaccinesJ Bubeník
Casopis Lekaru Ceskych|January 8, 1997
[Gene therapy of malignant tumors. Prospects of cytokine gene transfer vaccines]J Bubeník
Neoplasma|November 30, 2002
Therapeutic vaccines against HPV16-associated tumors. MinireviewJ Bubeník
Folia Biologica|September 18, 2004
Interleukin-2 therapy of cancerJ Bubeník
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Folia Biologica|March 24, 2000
Dendritic-cell-based cancer vaccinesJ Bubeník
International Journal of Oncology|February 17, 2001
Genetically engineered dendritic cell-based cancer vaccines (review)J Bubeník
Journal of Cancer Research and Clinical Oncology|August 15, 2001
Utilization of oncoprotein-pulsed dendritic cells as tumor vaccinesJ Bubeník
Journal of Cancer Research and Clinical Oncology|January 1, 1990
Local and regional immunotherapy of cancer with interleukin 2J Bubeník
Folia Biologica|January 1, 1993
IL-2 gene therapy of cancer: at its beginningJ Bubeník
Folia Biologica|February 19, 2010
Genetically modified vaccines augment the efficacy of cancer surgery and chemotherapyJ Bubeník
Folia Biologica|December 23, 2006
Depletion of Treg cells augments the therapeutic effect of cancer vaccinesJ Bubeník
Casopis Lekaru Ceskych|January 8, 1997
[Gene therapy of malignant tumors. Prospects of cytokine gene transfer vaccines]J Bubeník
Neoplasma|November 30, 2002
Therapeutic vaccines against HPV16-associated tumors. MinireviewJ Bubeník
Folia Biologica|September 18, 2004
Interleukin-2 therapy of cancerJ Bubeník
Pageof 15